0001770121-20-000002.txt : 20200626 0001770121-20-000002.hdr.sgml : 20200626 20200626134602 ACCESSION NUMBER: 0001770121-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200626 DATE AS OF CHANGE: 20200626 EFFECTIVENESS DATE: 20200626 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sana Biotechnology, Inc. CENTRAL INDEX KEY: 0001770121 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-369781 FILM NUMBER: 20992930 BUSINESS ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUIT 400 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: (206) 701-7914 MAIL ADDRESS: STREET 1: 188 EAST BLAINE STREET, SUIT 400 CITY: SEATTLE STATE: WA ZIP: 98102 D 1 primary_doc.xml X0708 D LIVE 0001770121 Sana Biotechnology, Inc. 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA WASHINGTON 98102 (206) 701-7914 DELAWARE None None Corporation true 2018 Steven D. Harr c/o Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 SEATTLE WA WASHINGTON 98102 Executive Officer Director Nathan Hardy c/o Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 SEATTLE WA WASHINGTON 98102 Executive Officer James J. MacDonald c/o Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 SEATTLE WA WASHINGTON 98102 Executive Officer Hans Bishop c/o Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 SEATTLE WA WASHINGTON 98102 Director Douglas Cole c/o Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 SEATTLE WA WASHINGTON 98102 Director Richard Mulligan c/o Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 SEATTLE WA WASHINGTON 98102 Director Robert Nelsen c/o Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 SEATTLE WA WASHINGTON 98102 Director Mary Agnes Wilderotter c/o Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 SEATTLE WA WASHINGTON 98102 Director Donald Payan c/o Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 SEATTLE WA WASHINGTON 98102 Director Geoffrey von Maltzahn c/o Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 SEATTLE WA WASHINGTON 98102 Director Stephen Knight c/o Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 SEATTLE WA WASHINGTON 98102 Director Patrick Yang c/o Sana Biotechnology, Inc. 188 East Blaine Street, Suite 400 SEATTLE WA WASHINGTON 98102 Director Biotechnology Decline to Disclose 06b false 2018-10-02 false true true true Series A-1 Preferred Stock; Common Stock issuable upon conversion thereof false 0 45850000 45850000 0 false 8 0 0 0 false Sana Biotechnology, Inc. /s/ Steven D. Harr Steven D. Harr President & Chief Executive Officer 2020-06-25